Skip to the page

Data / Form D filings / Vignette Bio, Inc.

Vignette Bio, Inc.: Form D filing

Vignette Bio, Inc., a health care company in San Diego, CA, filed a Form D with the SEC in 2024. The latest, on September 13, 2024, reports $105 million sold of a $105 million offering to 56 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11622 EL CAMINO REAL, SUITE 150, San Diego, CA, 92130
Phone
(858) 247-0550
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2035906

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 13, 2024New notice$105,000,000$105,000,00056Jul 17, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kenneth Song, M.D.Executive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of Sep 9, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Vignette Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.